News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,331 Results
Type
Article (29)
Press Release (3302)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Allergies (2)
Alliances (44)
Alzheimer's disease (31)
Antibody-drug conjugate (ADC) (4)
Approvals (113)
Artificial intelligence (1)
Autoimmune disease (2)
Bankruptcy (1)
Best Places to Work (297)
Breast cancer (11)
Cancer (106)
Cardiovascular disease (10)
Career advice (1)
Cell therapy (1)
Cervical cancer (1)
Clinical research (700)
Collaboration (5)
Compensation (4)
COVID-19 (4)
C-suite (1)
Data (153)
Depression (1)
Diabetes (1)
Diagnostics (22)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (1547)
Events (359)
FDA (163)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (5)
Generative AI (1)
Gene therapy (4)
GLP-1 (8)
Government (9)
Guidances (28)
Healthcare (85)
IgA nephropathy (3)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (161)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (40)
Lymphoma (15)
Manufacturing (3)
MASH (5)
Medical device (57)
Medtech (57)
Mergers & acquisitions (27)
Metabolic disorders (7)
Multiple sclerosis (7)
NASH (1)
Neuroscience (48)
NextGen: Class of 2025 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (3)
Pancreatic cancer (1)
Parkinson's disease (2)
Patient recruitment (1)
Peanut (1)
People (9)
Phase I (106)
Phase II (210)
Phase III (419)
Pipeline (128)
Policy (1)
Postmarket research (27)
Preclinical (13)
Prostate cancer (3)
Radiopharmaceuticals (6)
Rare diseases (10)
Regulatory (159)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (2)
Schizophrenia (4)
Sponsored (1)
Startups (3)
Vaccines (5)
Date
Last 7 days (15)
Last 30 days (20)
Last 365 days (420)
2025 (414)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (359)
Australia (14)
California (107)
Canada (26)
China (18)
Connecticut (5)
Delaware (20)
Europe (665)
Florida (13)
Georgia (2)
Illinois (10)
Indiana (20)
Japan (20)
Kansas (1)
Maryland (20)
Massachusetts (77)
Minnesota (9)
New Jersey (82)
New York (40)
North Carolina (13)
Northern California (72)
Ohio (4)
Pennsylvania (32)
South America (5)
Southern California (29)
Texas (16)
United States (477)
Utah (8)
Virginia (1)
Washington State (6)
3,331 Results for "%E2%80%9D%20%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lilly’s Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
December 10, 2025
·
18 min read
Press Releases
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes
December 9, 2025
·
19 min read
Press Releases
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
·
13 min read
Press Releases
Almirall’s 2025 9M Results
November 10, 2025
·
7 min read
Press Releases
Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025
December 8, 2025
·
6 min read
Press Releases
PureTech’s Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
December 8, 2025
·
10 min read
Press Releases
New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
November 4, 2025
·
16 min read
Press Releases
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
December 10, 2025
·
6 min read
Press Releases
Celldex Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 10, 2025
·
13 min read
Press Releases
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
December 12, 2025
·
23 min read
1 of 334
Next
